Actively Recruiting

Phase 3
Age: 18Years - 80Years
MALE
NCT06593665

Intrathecal Morphine Versus Intravenous Methadone for Postoperative Analgesia Following Retroperitoneal Lymph Node Dissection.

Led by Indiana University · Updated on 2026-02-13

142

Participants Needed

2

Research Sites

120 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This randomization study is to compare both intrathecal morphine and intravenous methadone, which are both standard of care, for pain management in patients undergoing retroperitoneal lymph node dissections for primary testicular cancer. Investigators plan to compare their analgesic effectiveness at different postoperative time intervals.

CONDITIONS

Official Title

Intrathecal Morphine Versus Intravenous Methadone for Postoperative Analgesia Following Retroperitoneal Lymph Node Dissection.

Who Can Participate

Age: 18Years - 80Years
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Male patients aged 18 to 80 years
  • Undergoing virgin or post-chemotherapy retroperitoneal lymph node dissection for primary testicular cancer at IU Health AAHC
  • ASA physical status class 1, 2, or 3
  • Body mass index (BMI) less than 50 kg/m2
Not Eligible

You will not qualify if you...

  • Any contraindication for neuraxial (spinal) analgesia
  • Use of home methadone at any dose
  • Physical, mental, or medical conditions that could affect accurate measurement of postoperative pain
  • Known allergy to morphine, bupivacaine, acetaminophen, or methadone
  • History of substance abuse including heroin or illegal drugs within the past 6 months
  • End stage liver disease or end stage renal disease
  • Remaining intubated after surgery
  • Taking more than 30 mg per day of oral morphine equivalent at home
  • Undergoing additional surgery with a different incision than standard laparotomy for RPLND

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Indiana Univeristy

Indianapolis, Indiana, United States, 46202

Actively Recruiting

2

Indiana University Hospital

Indianapolis, Indiana, United States, 46202

Actively Recruiting

Loading map...

Research Team

L

Lyla S Farlow

CONTACT

A

Angie Plummer

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here